AI’s transformative potential in clinical development relies on the industry's ability to rebuild its fractured data infrastructure.
Leigh Cohen
Advertisement
Articles by Leigh Cohen
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
Eli Lilly Breaks Ground on $3.5 billion Pennsylvania Manufacturing Site
2
FDA Pauses Commissioner’s National Priority Voucher Program: Report
3
Moderna Lays Out Oncology-Driven Growth Plan at 2026 Analyst Day
4
Pharmaceutical Executive Daily: FDA Shelves CNPV Program
5